Plasma membranes of cells from retroorbital tissue have been prepared from the Harderian glands of guinea pigs and have been characterized as being reasonably free of other subcellular structures by electron microscopy and by enzyme-marker analyses. Both bovine thyrotropin and a proteolytic derivative of bovine thyrotropin with exophthalmogenic activity but without thyroid-stimulating activity specifically bind to these membranes. Gammaglobulin from the sera of patients with malignant exophthalmos increases the binding of both pituitary factors, whereas binding is not similarly increased by gammaglobulin from the sera of individuals who are not exophthalmic. The increased binding caused by the gammaglobulin from exophthalmic patients is the same whether the sera are positive or negative for the longacting thyroid stimulator. Present binding experiments do not indicate a direct interaction between the gammaglobulin and the plasma membranes of the cells from Harderian glands. A mechanism for the pathogenesis of human exophthalmos is proposed on the basis of these data.
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Pituitary extracts produce exophthalmos and an accumulation of glycosaminoglycans in retro-orbital tissue when injected into several classes of animals (1) (2) (3) (4) (5) . In previous work, we demonstrated that the exophthalmogenic activity of these extracts could be ascribed to thyrotropin (TSH) (6) but that partial digestion of purified TSH with pepsin could result in an exophthalmogenic fragment of the TSH molecule that had no thyroid-stimulating activity (7) . The exophthalmogenic fragment of the TSH molecule had a molecular weight of about 20,000 and was composed of two polypeptide units, one with a molecular weight of about 14,000 and the other with a molecular weight of about 6000 (7) . Present evidence indicates that the heavier unit is a nearly intact # subunit of the TSH molecule and that the lighter unit is an amino-terminal fragment of the a subunit (8) .
The role of TSH or of an exophthalmogenic factor derived from TSH in the pathogenesis of exophthalmos has not been clear since increased TSH production has never been demonstrated in patients with exophthalmos and since several groups have demonstrated an exophthalmogenic activity in the gammaglobulin fraction of sera from patients with exophthalmos (9) (10) (11) . This latter activity is neutralized by human antigammaglobulin and is associated with the Fab' 2 fraction of the immunoglobulin molecule (9, 11) .
It is different from the long-acting thyroid stimulator (LATS), a factor that exhibits several characteristics of an antibody against thyroid antigens and is found more frequently in the serum of patients with Graves' disease (exophthalmic goiter) and exophthalmos than in the serum of patients with Graves' disease without occular symptoms (12, 13) . Since it is absent from the serum of some patients with malignant exophthalmos, LATS is not felt to be the immediate cause of the exophthalmopathy (14) .
In the present report, we demonstrate the specific binding of TSH and the exophthalmogenic fragment of TSH to plasma membranes of guinea pig Harderian gland. We also show that the gammaglobulin of both LATS-negative and LATSpositive sera from patients with exophthalmos significantly increases this binding.
On the basis of these data and our previous reports (6, 7), we postulate that human exophthalmos is a two-factor disease caused by the simultaneous presence of a derivative of the TSH molecule with no thyroid stimulating ability and by the presence of an "abnormal" gammaglobulin. We speculate that the derivative of the TSH molecule serves as the direct effector and that the gammaglobulin serves to target this effector by increasing its affinity to retro-orbital tissue.
MATERIALS AND METHODS
Preparation of Plasma Membranes. Plasma membranes from bovine thyroid and guinea pig liver and muscle were prepared by sucrose density gradient centrifugation according to the method of Neville (15) . Plasma membranes of Harderian gland of guinea pigs were similarly prepared. Harderian glands (3 g) were homogenized in 20 ml of 1 mM sodium bicarbonate (pH 7.5) by 10 strokes of a Potter-Elvehjem homogenizer. The homogenate was diluted four times with buffer, passed through four layers of cheese cloth, and centrifuged at 3000 X g for 10 min. After the resultant membrane pellet was washed three times with the same buffer, it was collected by centrifugation at the same speed. The final pellet, suspended in 1.5 ml of 20 mM Trist HCl (pH 7.5) containing 1 mM ethylenediaminetetraacetate (EDTA), was applied to a' sucrose density gradient, centrifuged, and collected as described (15) .
Membrane suspensions were stored at -70°in 0.5 ml of 20 mM Tris -HCl (pH 7.5) containing 1 mM EDTA. Membrane protein was determined by the procedure of Lowry et al. (16) Abbreviations: TSH, thyrotropin; LATS, long-acting thyroid stimulator.
FIG. 1.
Electron micrograph of plasma membranes prepared from Harderian glands of guinea pig. Membranes were fixed in 1% osmium tetroxide; the magnification is X25,000. Bottom frame depicts triple layer structure at high resolution. The electron micrographs were kindly taken by Dr. Charles Dechenne, University of Liege, Liege, Belgium.
after solubilization of the membrane in 0.1 ml of 1 N NaOH and heating at 1000 for 30 min.
Preparation of the 3H-labeled Glycoprotein Hormones and the '3II-Labeled Gammaglobulin. Purified [3H]TSH was prepared as described (6, 7) ; it contained 10-20 U/mg* of thyrotropic activity (17) and 10-20 U/mg* of exophthalmogenic activity (18, 19) . The 3H-labeled exophthalmogenic factor was obtained by pepsin digestion of purified [3H]TSH, followed by electrofocusing (8) . The thyrotropic activity of this factor was less than 0.1 U/mg, and its exophthalmogenic activity was about 10-20 U/mg.
Gammaglobulins of normal serum and of serum from patients with malignant exophthalmos were purified by chromatography on diethylaminoethyl (DEAE)-cellulose (20) . '311-labeled gammaglobulins were prepared by the procedure of Hunter and Greenwood (21) . 10 ,000 X g for 10 min. The supernatant was aspirated with a Pasteur pipette; 0.5 ml of a 10% sucrose solution was layered over the pellet and a second centrifugation at the same speed was performed. After aspiration of the sucrose solution, each pellet was suspended in 0.5 ml of distilled water and transferred to counting vials containing 10 ml of Aquasol (New England Nuclear). In order to calculate the amount of hormones specifically bound to the membranes, control incubations were performed without the membrane suspension. Gammaglobulin concentrations were adjusted so that they were the same in experimental and control incubations. The specific activity of the 3H-labeled hormonal preparations ranged from 250,000 cpm to 500,000 cpm/mg.
RESULTS

Purity of the plasma membranes of Harderian glands
The yield of purified membranes from Harderian gland tissue was 1 mg of protein per g of wet weight; for liver, muscle, or thyroid membranes, the yield was, respectively, 0.8, 0.5, and 0.7 mg of protein per g of wet weight. A typical electron micrograph of the plasma membranes of the Harderian gland is presented in Fig. 1 ; they appear to be large vesicles (7.5-9.5 nm; 75-95 A) with a triple-layer structure at higher magnification. Although contaminated with a minimum of other cellular components, rough endoplasmic reticulum and a less than 1% (17) . Exophthalmogenic activity is expressed relative to the activity of the crude TSH preparations and is quantitated as described (5) (6) (7) (8) . For definition of U, see refs. 6 and 7. contamination by mitochondria were observed. The activity of various enzyme markers is given in Table 1 ; by comparison to data obtained from other membrane preparations (23, 24) , the concentrations of membrane-bound enzymes (5'-nucleotidase, ATPase) are increased, while those of the enzymes that are not bound to membranes are reduced. Gammaglobulin isolated from the serum of patients with exophthalmos increased the binding of both TSH and the exophthalmogenic factor to the plasma membranes of Harderian glands (Fig. 4) . This effect was most pronounced in the second phase of the binding curve and was relatively greater in its influence on the binding of the exophthalmogenic factor; however, dissociation constants calculated for the high affinity site (first phase of binding, see Fig. 2 ) were also altered by at least one order of magnitude. Slope calculations suggest that the gammaglobulin effects changes in affinity rather than changes in total-binding capacity. Equivalent amounts of gammaglobulin from the sera of normal patients stimulated specific hormonal binding only slightly (Fig. 4) human serum proteins, casein, or bovine serum albumin had no effect (data not shown). Gammaglobulin from the sera of either LATS-positive or LATS-negative exophthalmos patients was equally effective, and both had an optimal effect at a concentration of 50 Ag/ml of added protein (Fig. 5) . Binding of '3I1-labeled gammaglobulin to the plasma membranes of phthalmogenic gammaglobulin, and in both cases binding was decreased over 80% by dilution with unlabeled gammaglobulin from either the same or the opposite source.
Gammaglobulin has been reported to increase hormonal activity by prolonging the half-life of circulating hormones in vivo (25) . By the use of mice and dosages of abnormal gammaglobulin previously recognized to change the retroorbital concentration of glycosaminoglycans (5, 26, 27) , the half-life of [3H]TSH and 3H-labeled exophthalmogenic factor was measured. In the presence or absence of normal or exophthalmogenic gammaglobulin, the half-life and decay curves were the same for both pituitary factors. DISCUSSION We have previously demonstrated that either purified TSH or an exophthalmogenic derivative of TSH with no significant thyroid-stimulating activity can produce exophthalmos and the associated changes in the concentration of glycosaminoglycans in experimental animals (6) (7) (8) . In the present report, we demonstrate that both TSH and its exophthalmogenic derivative bind specifically to the plasma membranes of cells of retro-orbital tissue and that gammaglobulin from the sera of patients with exophthalmos will significantly improve this binding.
On the basis of these data and our previous reports (6) (7) (8) , we postulate that human exophthalmos is a two-factor disease requiring the simultaneous presence of a derivative of the TSH molecule that has lost its thyroid-stimulating ability and an "abnormal" gammaglobulin. We speculate that the pituitary hormonal derivative serves as the direct effector and that the gammaglobulin "targets" this effector by increasing its affinity to retro-orbital tissue. The requirement for two factors rather than one alone would explain the low incidence of exophthalmos in Graves' disease; the fact that the TSH derivative is Proc. Nat. Acad. Sci. USA 69 (1972) without thyroid-stimulating ability would explain the present failure to detect significant TSH activity in the sera of patients with Graves' disease (30) . t The TSH derivative could be a proteolytic fragment of TSH analogous to the exophthalmogenic factor that was also produced by digestion with pepsin, or could be the subunit, which has 10-30% of the exophthalmogenic activity of this factor (31) . Since the production of a TSH derivative without thyroid-stimulating ability could be a consequence of high circulating concentrations of thyroid hormone, i.e., a consequence of a feedback mechanism reducing the production of a native TSH molecule, the absence of the gammaglobulin factor in other cases of hyperthyroidism (functioning adenomas, exogenous thyroid) could explain the absence of exophthalmos in these disease conditions.
The mechanism of the increased hormonal binding induced by gammaglobulin is unclear. Present evidence that indicates no direct interaction of the gammaglobulin alone with the membranes is compatible with the finding that direct and indirect immunologic techniques have not detected gammaglobulin interactions with retro-orbital tissue (32) . The origin or nature of the gammaglobulin is also unclear. All the patients with Graves' disease and active exophthalmos that have been tested have a circulating gammaglobulin that induces exophthalmos in fish (9) (10) (11) . All the patients with Graves' disease and active exophthalmos that have been tested also have leukocyte-bound antibodies that interact with antigens from retro-orbital and thyroid tissue (33) . It is clear, however, that LATS is not the globulin affecting binding (Fig. 5 ) nor inducing exophthalmos in fish (9) (10) (11) .
The possibility is thus raised that patients with Graves' disease have a spectrum of abnormal globulins that are present at different concentrations and that the two-factor mechanism is common. Patients with pretibial myxedema could thus have an abnormal gammaglobulin that causes increased binding of the TSH derivative to the skin. This possibility is compatible with the finding that patients with pretibial myxedema, unlike the usual patients with Graves' disease, have leukocyte-bound antibodies that interact with skin antigens (33) . The postulate that the two-factor mechanism is common must be considered, since the changes in the concentration of glycosaminoglycan observed in exophthalmic patients are not restricted to retroorbital issue, i.e., TSH and its exophthalmogenic derivative induce changes in the concentration of glycosaminoglycan in such diverse tissues as perirenal fat, small intestine, and pancreas (5, 26, 27 
